AIM ImmunoTech And 3 Other Stocks Under $1 Insiders Are Buying

The Dow Jones closed lower by over 50 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

SeaStar Medical

• The Trade: SeaStar Medical Holding Corporation (NASDAQ:ICU) Director Kenneth Heel Van acquired a total of 100,000 shares an average price of $0.40. To acquire these shares, it cost around $40,000.
• What’s Happening: SeaStar Medical posted a wider-than-expected quarterly loss.
• What SeaStar Medical Does: SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs.

Beasley Broadcast Group

• The Trade: Beasley Broadcast Group, Inc. (NASDAQ:BBGI) CEO Caroline Beasley acquired a total of 2,712 shares at an average price of $0.72. To acquire these shares, it cost around $1,952.
• What’s Happening: Beasley Broadcast Group posted a loss for the third quarter.
• What Beasley Broadcast Group Does: Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States.

Check This Out: Investor Sentiment Declines As US Stocks Settle Lower

RiskOn International

• The Trade: RiskOn International, Inc. (NASDAQ:ROI) 10% owner Milton C. Ault III acquired a total of 2,133 shares at an average price of $0.39. The insider spent around $837 to buy those shares.
• What’s Happening: The company’s stock dipped 50% over the past month.
• What RiskOn International Does: RiskOn International Inc is a holding company which owns BitNile metaverse platform that allows users to engage with a new social networking community and purchase both digital and physical products while playing 3D immersive games.

AIM ImmunoTech

• The Trade: AIM ImmunoTech Inc. (NYSE:AIM) CEO and President Thomas K Equels acquired a total of 33,861 shares at an average price of $0.44. The insider spent around 15,000 to buy those shares.
• What’s Happening: AIM ImmunoTech posted a wider-than-expected third-quarter loss.
• What AIM ImmunoTech Does: AIM ImmunoTech Inc is an immuno-pharma company focused on research and development of therapeutics to treat immune disorders, viral and cancer diseases.

Don’t forget to check out our premarket coverage here